SIREN : 893405456
L'AMARANTE BIO is a French company founded 5 years ago, specialized in the sector Supérettes. Based in SAINT-CLAIR-DU-RHONE (38370), this company of category PME shows in 2022 a revenue of 1.2 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-02
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | N/C | N/C | N/C | 1 218 505 € |
| Net income | 33 066 € | 90 766 € | 15 547 € | -137 967 € |
| EBITDA | N/C | N/C | N/C | -77 014 € |
| Net margin | N/C | N/C | N/C | -11.3% |
In 2025, L'AMARANTE BIO generates positive net income of 33 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.
33 066 €
The debt ratio (= Financial debt / Equity x 100) stands at 2097%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 3%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
2096.507%
3.358%
50.8%
In 2025, the debt ratio of L'AMARANTE BIO (2096.51) ranks in the top 25% of the sector. This ratio measures the weight of debt relative to equity. A high ratio may indicate excessive dependence on external financing.
In 2025, the financial autonomy of L'AMARANTE BIO (3.4%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.
The liquidity ratio (= Current assets / Current liabilities) stands at 205.91. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
205.905
In 2025, the liquidity ratio of L'AMARANTE BIO (205.91) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
0 €
0 j
0 j
0 j
Based on 270 transactions of similar company sales in 2025, the value of L'AMARANTE BIO is estimated at 208 250 € (range 84 184€ - 501 000€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Only this financial indicator is available for this company.
This estimate is based on the analysis of 270 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare L'AMARANTE BIO with other companies in the same sector:
The revenue of L'AMARANTE BIO in 2022 is 1.2 M€.
Yes, L'AMARANTE BIO generated a net profit of 33 k€ in 2025.
The headquarters of L'AMARANTE BIO is located in SAINT-CLAIR-DU-RHONE (38370), in the department Isere.
The tax return of L'AMARANTE BIO is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
L'AMARANTE BIO operates in the sector Supérettes (NAF code 47.11C). See the 'Sector positioning' section above to compare the company with its competitors.